Download PDF
CC BY 4.0 · Indian J Med Paediatr Oncol 2024; 45(02): 153-156
DOI: 10.1055/s-0043-1777354
Original Article

Clinical Profile of Male Patients Presenting with Breast Cancer in Kashmir Valley

Ulfat Ara Wani
1   Department of Medical Oncology, Sher-i-Kashmir institute of Medical Sciences, Soura Srinagar, Jammu and Kashmir, India
,
Umeek Jeelani
2   Department of ENT, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India
,
Basharat Ara Wani
2   Department of ENT, Government Medical College Srinagar, Srinagar, Jammu and Kashmir, India
,
Shahida Nasreen
3   Department of Radiation Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Introduction Breast cancer is a rare disease in males with unknown etiology and variable rate of incidence among different ethnic and geographical groups.

Objectives This article studies the clinical profile of male breast cancer in Kashmir Valley of India

Materials and Methods This study was a retrospective study conducted at a superspecialty hospital (Government Medical College Srinagar) in the department of medical oncology over a period of 4 years from January 2017 to October 2021. All male patients who presented with a histopathology-proven diagnosis of breast cancer were included and studied.

Results A total of 8 male patients with breast cancer were studied. The median age at diagnosis was 55 years. Most of the patients were from rural background. The most common presenting symptom was breast lump followed by ulceration. The most common location of the tumor was retroareolar. Infiltrating ductal carcinoma (100%) was the only subtype present in our patients. Locally advanced disease accounted for most of the cases. Among stage IV patients two had bone as the metastatic site and one patient had in addition lung metastasis. Immunohistochemistry analysis revealed that all patients (100%) were hormone receptor positive with only one patient being triple positive (12.5%). None of the patients had triple negative disease in our study. In our study 6 patients were treated with multimodalities (surgery, chemo, radiation, and targeted agents).

Conclusion Male breast cancer is a well-recognized entity and the gender gap of disease need to be abolished. Awareness among masses and training of general practitioners is needed to pick cases at early stage.

Keywords

male breast cancer - triple negative - ductal carcinoma - lung metastasis

Patient Consent

None declared




Publication History

Article published online:
21 March 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Pothamsetty RK, Ghosh RR, Thaliath BP. Characteristics and treatment outcomes of male breast cancer reported to regional cancer centre, India. Cancer Rep Rev 2017; 2 (01) 1-4
    Google Scholar
  • 2 Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006; 367 (9510): 595-604
    CrossrefPubMedGoogle Scholar
  • 3 Harnden DG, Maclean N, Langlands AO. Carcinoma of the breast and Klinefelter's syndrome. J Med Genet 1971; 8 (04) 460-461
    CrossrefPubMedGoogle Scholar
  • 4 Sharma D, Singh G. Male breast cancer: an overview. J Radiat Cancer Res 2017; 8: 98102
    CrossrefGoogle Scholar
  • 5 Price WH, Clayton JF, Wilson J, Collyer S, De Mey R. Causes of death in X chromatin positive males (Klinefelter's syndrome). J Epidemiol Community Health 1985; 39 (04) 330-336
    CrossrefPubMedGoogle Scholar
  • 6 Basham VM, Lipscombe JM, Ward JM. et al. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 2002; 4 (01) R2
    CrossrefPubMedGoogle Scholar
  • 7 Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer?. Breast Cancer Res Treat 2004; 83 (01) 77-86
    CrossrefPubMedGoogle Scholar
  • 8 Friedman LS, Gayther SA, Kurosaki T. et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 1997; 60 (02) 313-319
    PubMedGoogle Scholar
  • 9 McLaughlin JK, Malker HS, Blot WJ, Weiner JA, Ericsson JL, Fraumeni Jr JF. Occupational risks for male breast cancer in Sweden. Br J Ind Med 1988; 45 (04) 275-276
    PubMedGoogle Scholar
  • 10 Hansen J. Elevated risk for male breast cancer after occupational exposure to gasoline and vehicular combustion products. Am J Ind Med 2000; 37 (04) 349-352
    CrossrefPubMedGoogle Scholar
  • 11 Sasco AJ, Lowenfels AB, Pasker-de Jong P. Review article: epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected aetiological factors. Int J Cancer 1993; 53 (04) 538-549
    CrossrefPubMedGoogle Scholar
  • 12 Ron E, Ikeda T, Preston DL, Tokuoka S. Male breast cancer incidence among atomic bomb survivors. J Natl Cancer Inst 2005; 97 (08) 603-605
    CrossrefPubMedGoogle Scholar
  • 13 Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14 (01) 20-26
    CrossrefPubMedGoogle Scholar
  • 14 Thomas DB, Jimenez LM, McTiernan A. et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol 1992; 135 (07) 734-748
    CrossrefPubMedGoogle Scholar
  • 15 Johnson KC, Pan S, Mao Y. Canadian Cancer Registries Epidemiology Research Group. Risk factors for male breast cancer in Canada, 1994-1998. Eur J Cancer Prev 2002; 11 (03) 253-263
    CrossrefPubMedGoogle Scholar
  • 16 McCLURE JA, Higgins CC. Bilateral carcinoma of male breast after estrogen therapy. J Am Med Assoc 1951; 146 (01) 7-9
    CrossrefPubMedGoogle Scholar
  • 17 Soliman M, Hetnał M. Male breast cancer: a clinicopathological study of an Egyptian population (Alexandria experience). Contemp Oncol (Pozn) 2016; 20 (04) 335-340
    PubMedGoogle Scholar
  • 18 Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer?. Breast Cancer Res Treat 2004; 83 (01) 77-86
    CrossrefPubMedGoogle Scholar
  • 19 Sundriyal D, Kotwal S, Dawar R, Parthasarathy KM. Male breast cancer in India: series from a cancer research centre. Indian J Surg Oncol 2015; 6 (04) 384-386
    CrossrefPubMedGoogle Scholar
  • 20 Khalil AI, Mestaghanmi H, Qachach F, Saile R, Bendahhou K, Benider A. Breast cancer in men: characteristics epidemiological, clinicopathological and therapeutic. OAlib 2016; 3: e3166
    CrossrefGoogle Scholar
  • 21 Ram D, Rajappa SK, Selvakumar VP. et al. Male breast cancer: a retrospective review of clinical profile from a tertiary cancer care center of India. South Asian J Cancer 2017; 6 (04) 141-143
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Staruch RMT, Rouhani MJ, Ellabban M. The surgical management of male breast cancer: time for an easy access national reporting database?. Ann Med Surg (Lond) 2016; 9: 41-49
    CrossrefPubMedGoogle Scholar
  • 23 Mitra D, Manna A, Sikdar SK, Sur PK. Clinicopathological study and its prognostic implication in male breast carcinoma. J Indian Med Assoc 2007; 105 (12) 681-683 , 686
    PubMedGoogle Scholar